![Deborah Andrews](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Deborah Andrews
Direktor/Vorstandsmitglied bei LINEAGE CELL THERAPEUTICS, INC.
Vermögen: 15 578 $ am 31.05.2024
Aktive Positionen von Deborah Andrews
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
LINEAGE CELL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.04.2014 | - |
Independent Dir/Board Member | 11.04.2014 | - |
Karriereverlauf von Deborah Andrews
Ehemalige bekannte Positionen von Deborah Andrews
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
STAAR SURGICAL COMPANY | Comptroller/Controller/Auditor | 01.09.2013 | - |
Finanzdirektor/CFO | 28.04.2017 | 06.07.2020 | |
Corporate Officer/Principal | 01.01.1999 | 01.01.2001 | |
STAAR Surgical AG
![]() STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Finanzdirektor/CFO | 01.01.2001 | 01.01.2001 |
Bourns, Inc.
![]() Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Comptroller/Controller/Auditor | 01.01.1994 | 01.01.1995 |
KPMG Peat Marwick LLP | Comptroller/Controller/Auditor | 01.01.1991 | 01.01.1994 |
Ausbildung von Deborah Andrews
California State University-San Bernardino | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Schweiz | 2 |
Operativ
Comptroller/Controller/Auditor | 3 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Producer Manufacturing | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
STAAR SURGICAL COMPANY | Health Technology |
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Bourns, Inc.
![]() Bourns, Inc. Electrical ProductsProducer Manufacturing Bourns, Inc. manufactures and distributes electronic components. The firm products include automotive, circuit protection, outside plant products, connectors, diodes, encoders and pro lighting. It serves a broad range of markets, including automotive, industrial, consumer, communications, non-critical life support medical, audio, and various other market segments. The company was founded by Marlan Bourns and Rosemary Bourns in 1947 and is headquartered in Riverside, CA. | Producer Manufacturing |
KPMG Peat Marwick LLP | Commercial Services |
STAAR Surgical AG
![]() STAAR Surgical AG Medical SpecialtiesHealth Technology Part of STAAR Surgical Co., STAAR Surgical AG is a Swiss company that designs, develops, manufactures, and markets implantable lenses for the eye with companion delivery systems. The company is based in Nidau, Switzerland. The company's lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The company offers refractive solutions for myopia, hyperopia, and astigmatism, as well as cataract solutions. The company's innovative products are designed to conveniently deliver high-quality intraocular lenses through a small incision in a predictable, efficient manner. The company has sold over 2 million collamer lenses worldwide and has over 900 employees, marketing lenses in over 75 countries. | Health Technology |
- Börse
- Insiders
- Deborah Andrews
- Erfahrung